Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Storing hair follicle micrografts for longer times can cause them to enter a state similar to the natural hair shedding phase, which might impact hair transplant results.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

miR-29 is a key factor that accelerates aging.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Wnt1a-conditioned medium from stem cells helps activate cells important for hair growth and can promote hair regrowth.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Melatonin may help treat PCOS symptoms in rats.

Lespedeza cuneata extract may help treat enlarged prostate.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

The document explains how male reproductive hormones work and affect the body.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Ecklonia cava polyphenols help increase human hair growth and reduce hair loss.